Budamate 200 Transcaps is a prescription drug, available for use as Transcaps. It is typically used for the treatment of Asthma. Secondary and off-label uses of Budamate 200 Transcaps have also been mentioned below.
The optimal dosage of Budamate 200 Transcaps is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Budamate 200 Transcaps also has some side effects, the most common being Nasopharyngitis, Headache, Back Pain. Some other side effects of Budamate 200 Transcaps have been listed ahead. Normally, these side effects of Budamate 200 Transcaps are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Budamate 200 Transcaps is Moderate for pregnant women and Moderate for women who are breastfeeding. Further, the section on Budamate 200 Transcaps related warnings talks about Budamate 200 Transcaps's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Budamate 200 Transcaps contraindications section.
Drug interactions for Budamate 200 Transcaps have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Budamate 200 Transcaps is safe while driving, and is addiction.
Budamate 200 Transcaps is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Budamate 200 Transcaps safe for pregnant women?
Pregnant women may experience moderate side effects from Budamate. It is best to stop taking Budamate immediately and inform your doctor if you notice any discomfort.
Is the use of Budamate 200 Transcaps safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Budamate. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Budamate 200 Transcaps on the Kidneys?
Budamate is not harmful for kidneys.
What is the effect of Budamate 200 Transcaps on the Liver?
Using Budamate does not have any harmful effects on the liver.
What is the effect of Budamate 200 Transcaps on the Heart?
Very few cases of side effects of Budamate on the heart have been reported.
Budamate 200 Transcaps should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Budamate 200 Transcaps unless your doctor advises you to do so -
Is this Budamate 200 Transcaps habit forming or addictive?
Budamate 200 Transcaps does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Budamate 200 Transcaps as it does not make you drowsy.
Is it safe?
Yes, but take Budamate 200 Transcaps only as per medical advice.
Is it able to treat mental disorders?
No, Budamate 200 Transcaps cannot treat any kind of mental disorder.
Interaction between Food and Budamate 200 Transcaps
It is safe to take Budamate 200 Transcaps with food.
Interaction between Alcohol and Budamate 200 Transcaps
Taking Budamate 200 Transcaps with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca